Does Hereditary Spherocytosis Cause Hepatosplenomegaly?
Yes, hereditary spherocytosis (HS) characteristically causes splenomegaly and can cause hepatomegaly, making hepatosplenomegaly a common clinical manifestation of this disease.
Clinical Presentation
Splenomegaly is one of the cardinal features of hereditary spherocytosis and occurs in the vast majority of patients. In a large case series, 94.5% of HS patients had splenomegaly (with spleens extending up to 17 cm below the costal margin), while 71.7% had hepatomegaly (extending up to 6 cm below the costal margin) 1. The classic triad of HS includes:
- Hemolytic anemia
- Jaundice (present in ~67% of cases)
- Splenomegaly
Mechanism of Organomegaly
The splenomegaly in HS results from:
- Chronic hemolysis: Defective red blood cell membrane proteins (spectrin, ankyrin, band 3) lead to spherical erythrocytes that are prematurely destroyed in the spleen
- Splenic sequestration: The spleen becomes enlarged from continuous trapping and destruction of abnormal spherocytes
- Extramedullary hematopoiesis: Compensatory response to chronic anemia
The hepatomegaly occurs due to:
- Chronic hemolysis with increased bilirubin processing
- Extramedullary hematopoiesis
- Iron deposition from chronic hemolysis
Severity and Complications
Splenomegaly can become massive in HS. Recent case reports document spleens reaching 35 × 20 × 10 cm and weighing up to 10 kg 2. This degree of splenomegaly can cause:
- Abdominal discomfort and pain (reported in 35.8% of patients) 1
- Early satiety
- Mechanical compression of adjacent organs
Important Clinical Pitfalls
Do not assume normal spleen size rules out HS. While splenomegaly is present in the vast majority, some patients may have less pronounced splenic enlargement, particularly:
- Early in the disease course
- In milder variants
- In young children before significant hemolysis has occurred
Hepatosplenomegaly with iron overload can occur when HS coexists with hemochromatosis, as documented in a case where NGS revealed both SLC4A1 mutation (causing HS) and HFE gene variants 3. This represents a rare scenario where two hematological conditions counteract each other.
Diagnostic Confirmation
When hepatosplenomegaly is present with jaundice, confirm HS by:
- Peripheral blood smear: Spherocytes (present in 100% when carefully examined) 1
- Elevated reticulocyte count: Indicates active hemolysis
- Osmotic fragility test: Increased in HS
- Genetic testing: ANK1, SPTB, SLC4A1 mutations 4, 5
Critical caveat: Spherocytes are frequently missed on initial review—in one series, spherocytes were missed in 86.6% of patients investigated elsewhere 1. Careful examination of the peripheral smear is essential.
Management Implications
The presence of significant hepatosplenomegaly in HS typically indicates:
- Active chronic hemolysis requiring intervention
- Increased risk of gallstone formation (present in 37% of investigated patients) 1
- Potential need for splenectomy if symptomatic
Splenectomy effectively reduces hemolysis and resolves splenomegaly-related symptoms 2. However, partial splenectomy carries a 58% risk of recurrent splenomegaly, with 19% requiring completion splenectomy at a median of 10.5 years 6.